Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Absci Q3 2026 Results Announced November 12

Absci Corporation filed a Form 8-K on November 12, 2026, announcing its financial results for the third quarter ended September 30, 2026, and releasing a corporate presentation with internal pipeline program updates.

Anjali Anand | 12 November 2026

Artisan Partners Discloses 3.4% Stake in Twist Bioscience

Artisan Partners Asset Management Inc. and affiliated entities filed Amendment No. 7 to Schedule 13G with the SEC on November 12, 2026, reporting beneficial ownership of approximately 3.4% of Twist Bioscience Corporation common stock as of September 30, 2026.

Anjali Anand | 12 November 2026

Vor Biopharma Adds RC298 License, Issues $10M Payment and Warrant to RemeGen

Vor Biopharma Inc. filed a Current Report on Form 8-K on November 12, 2026, disclosing that on November 11, 2026, the company entered into an amended and restated license agreement with RemeGen Co., Ltd. that expands the existing telitacicept license to include a second …

Aakashdeep | 12 November 2026

Twist Bioscience Files 8-K for Fiscal Q4 and Full Year 2026 Results

Twist Bioscience Corporation filed a Form 8-K on November 12, 2026, announcing the release of its financial results for the quarter and fiscal year ended September 30, 2026.

Manish Choudhary | 12 November 2026

Enovix Reports Q3 2026 Financial Results via 8-K

Enovix Corporation filed a Form 8-K with the U.S. Securities and Exchange Commission on November 12, 2026, announcing the release of its financial results for the third fiscal quarter of 2026.

Nitish Kishor | 12 November 2026

Intuitive Machines Files Q3 2026 Earnings 8-K on Nov. 12

Intuitive Machines, Inc. filed a Form 8-K current report on November 12, 2026, disclosing the issuance of a press release announcing its financial results for the fiscal quarter ended September 30, 2026.

Manish Choudhary | 12 November 2026

Capstone Holding Q3 2026 Results 8-K, November 12

Capstone Holding Corp. filed a Form 8-K with the SEC on November 12, 2026, announcing the release of its financial and operating results for the quarter ended September 30, 2026, along with an accompanying investor presentation.

Vinay Lochav | 12 November 2026

News Corp Files ASX Repurchase Disclosures, Nov 11 2026

News Corporation filed a Form 8-K on November 12, 2026, reporting the submission of daily stock repurchase transaction disclosures to the Australian Securities Exchange as required under ASX rules, with the earliest event date of November 11, 2026.

Vinay Lochav | 12 November 2026

Skye Bioscience Wins Retrial Jury Verdict in Cunning Case

Skye Bioscience, Inc. filed a current report on November 12, 2026, disclosing that on November 10, 2026, a jury returned a unanimous verdict in favor of the company on all claims following a retrial in the Wendy Cunning vs. Skye Bioscience, Inc. matter in …

Shwetambri Chauhan | 12 November 2026

Sagimet Biosciences Q3 2026 Financial Results 8-K

Sagimet Biosciences Inc. filed a Current Report on Form 8-K on November 12, 2026, announcing its financial results for the quarter ended September 30, 2026, and furnishing an updated investor presentation under Regulation FD.

Anjali Anand | 12 November 2026
Support

Hi! How can we help you today?

Loading…